國立虎尾科技大學 |

Nuclear Medicine and Immunology

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Nuclear Medicine and Immunology/ edited by Sara Harsini, Abass Alavi, Nima Rezaei.
其他作者:	Rezaei, Nima.
面頁冊數:	XIV, 534 p. 112 illus., 101 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Nuclear Medicine. -
電子資源:	https://doi.org/10.1007/978-3-030-81261-4
ISBN:	9783030812614

Nuclear Medicine and Immunology
Nuclear Medicine and Immunology[electronic resource] /edited by Sara Harsini, Abass Alavi, Nima Rezaei. - 1st ed. 2022. - XIV, 534 p. 112 illus., 101 illus. in color.online resource.

1. Molecular Imaging in Inflammatory and Autoimmune Disorders -- 2. Gallium Imaging of Infection and Inflammation -- 3. 111Indium-Labeled Leukocyte Imaging of Infection and Inflammation -- 4. 99mTc-HMPAO-Labeled-Leukocyte Imaging of Infection and Inflammation -- 5. FDG-PET Imaging of Infection and Inflammation -- 6. Imaging Procedures with Radiolabeled Monoclonal Antibodies -- 7. Dosimetric Principles of Targeted Radiotherapy -- 8. Radioimmunotherapy (RIT) -- 9. Peptide Receptor Radionuclide Therapy (PRRT) -- 10. Tumor Architecture and Targeted Delivery -- 11. Antibodies and Novel Constructs for Tumor Targeting -- 12. Pretargeted Radioimmunotherapy of Cancer -- 13. Radioimmunotherapy of Lymphoma -- 14. Radioimmunotherapy in Brain Tumors -- 15. Radioimmunotherapy of Pancreatic Adenocarcinoma -- 16. Radioimmunotherapy of Renal Cell Carcinoma -- 17. Radioimmunotherapy of Prostate Carcinoma -- 18. Radioimmunotherapy of Ovarian Cancer -- 19. Targeted Radiotherapy in the Treatment of Osteosarcoma -- 20. Targeted Radiotherapy of Neuroblastoma -- 21. Targeted Radiotherapy of Squamous Cell Carcinoma of the Head and Neck -- 22. Moving Forward: Expected Opportunities for the Development of New Therapeutic Agents -- 23. Translation of Radiopharmaceuticals from Bench to Bedside.

This book explores the close connection between immunology and nuclear medicine, which has led to radioimmunoimaging and radioimmunotherapy (RIT). Molecular imaging with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) is increasingly being used to diagnose, characterize, and monitor disease activity in the context of inflammatory disorders of known and unknown etiology, such as sarcoidosis, atherosclerosis, vasculitis, inflammatory bowel disease, rheumatoid arthritis, and degenerative joint disease. The first chapters discuss the various radiopharmaceutical agents and radiolabeled preparations that have been employed in inflammation imaging. Of these, FDG-PET imaging has been shown to have the great value in the detection of inflammation and has become the centerpiece of several initiatives over the last several years. This very powerful technique will play an increasingly important role in the management of patients with inflammatory conditions in the future. The book also explores the growing role of nuclear medicine and molecular imaging in the diagnosis and treatment of cancer. The rapid pace of change has been fueled by advances in our understanding of tumor biology, on the one hand, and the development of specifically targeted medical therapies, diagnostic agents, and radiotherapies, on the other. Written by leading international experts in the field, this book is an invaluable tool for nuclear medicine physicians, radiologists, oncologists, and immunologists.

ISBN: 9783030812614

Standard No.: 10.1007/978-3-030-81261-4doiSubjects--Topical Terms:

673045
Nuclear Medicine.

LC Class. No.: R895-920

Dewey Class. No.: 616.0757

Nuclear Medicine and Immunology
LDR:04155nam a22003975i 4500 001 1091000
003 DE-He213
005 20220120150838.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030812614 $9 978-3-030-81261-4
024 7 $a 10.1007/978-3-030-81261-4 $2 doi
035 $a 978-3-030-81261-4
050 4 $a R895-920
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.0757 $2 23
245 1 0 $a Nuclear Medicine and Immunology $h [electronic resource] / $c edited by Sara Harsini, Abass Alavi, Nima Rezaei.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XIV, 534 p. 112 illus., 101 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Molecular Imaging in Inflammatory and Autoimmune Disorders -- 2. Gallium Imaging of Infection and Inflammation -- 3. 111Indium-Labeled Leukocyte Imaging of Infection and Inflammation -- 4. 99mTc-HMPAO-Labeled-Leukocyte Imaging of Infection and Inflammation -- 5. FDG-PET Imaging of Infection and Inflammation -- 6. Imaging Procedures with Radiolabeled Monoclonal Antibodies -- 7. Dosimetric Principles of Targeted Radiotherapy -- 8. Radioimmunotherapy (RIT) -- 9. Peptide Receptor Radionuclide Therapy (PRRT) -- 10. Tumor Architecture and Targeted Delivery -- 11. Antibodies and Novel Constructs for Tumor Targeting -- 12. Pretargeted Radioimmunotherapy of Cancer -- 13. Radioimmunotherapy of Lymphoma -- 14. Radioimmunotherapy in Brain Tumors -- 15. Radioimmunotherapy of Pancreatic Adenocarcinoma -- 16. Radioimmunotherapy of Renal Cell Carcinoma -- 17. Radioimmunotherapy of Prostate Carcinoma -- 18. Radioimmunotherapy of Ovarian Cancer -- 19. Targeted Radiotherapy in the Treatment of Osteosarcoma -- 20. Targeted Radiotherapy of Neuroblastoma -- 21. Targeted Radiotherapy of Squamous Cell Carcinoma of the Head and Neck -- 22. Moving Forward: Expected Opportunities for the Development of New Therapeutic Agents -- 23. Translation of Radiopharmaceuticals from Bench to Bedside.
520 $a This book explores the close connection between immunology and nuclear medicine, which has led to radioimmunoimaging and radioimmunotherapy (RIT). Molecular imaging with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) is increasingly being used to diagnose, characterize, and monitor disease activity in the context of inflammatory disorders of known and unknown etiology, such as sarcoidosis, atherosclerosis, vasculitis, inflammatory bowel disease, rheumatoid arthritis, and degenerative joint disease. The first chapters discuss the various radiopharmaceutical agents and radiolabeled preparations that have been employed in inflammation imaging. Of these, FDG-PET imaging has been shown to have the great value in the detection of inflammation and has become the centerpiece of several initiatives over the last several years. This very powerful technique will play an increasingly important role in the management of patients with inflammatory conditions in the future. The book also explores the growing role of nuclear medicine and molecular imaging in the diagnosis and treatment of cancer. The rapid pace of change has been fueled by advances in our understanding of tumor biology, on the one hand, and the development of specifically targeted medical therapies, diagnostic agents, and radiotherapies, on the other. Written by leading international experts in the field, this book is an invaluable tool for nuclear medicine physicians, radiologists, oncologists, and immunologists.
650 1 4 $a Nuclear Medicine. $3 673045
650 0 $a Immunology. $3 592892
650 0 $a Radiology. $3 673943
650 0 $a Oncology. $3 593951
650 0 $a Nuclear medicine. $3 673902
700 1 $a Rezaei, Nima. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 882367
700 1 $a Alavi, Abass. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 674178
700 1 $a Harsini, Sara. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1398522
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030812607
776 0 8 $i Printed edition: $z 9783030812621
776 0 8 $i Printed edition: $z 9783030812638
856 4 0 $u https://doi.org/10.1007/978-3-030-81261-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)